Literature DB >> 21933882

TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.

Hai Lu1, Xinping Yang, Praveen Duggal, Clint T Allen, Bin Yan, Jonah Cohen, Liesl Nottingham, Rose-Anne Romano, Satrajit Sinha, Kathryn E King, Wendy C Weinberg, Zhong Chen, Carter Van Waes.   

Abstract

Inflammation-induced activation of proto-oncogenic NF-κB/REL and dysfunction of tumor suppressor TP53/p63/p73 family transcription factors are key events in cancer progression. How inflammatory signaling coordinates dysregulation of these two transcription factor families during oncogenesis remains incompletely understood. Here, we observed that oncoprotein c-REL and tumor suppressor TAp73 are coexpressed and complex with ΔNp63α in the nucleus of a subset of head and neck squamous cell carcinoma (HNSCC) cell lines with mutant (mt)TP53. TNF-α, a proinflammatory cytokine, promoted c-REL nuclear translocation, c-REL/ΔNp63α interaction, and dissociation of TAp73 from ΔNp63α and the nucleus to the cytoplasm, whereas c-REL siRNA knockdown attenuated this effect. Overexpression of c-REL or a c-REL κB-site DNA-binding mutant enhanced protein interaction with ΔNp63α and TAp73 dissociation, implicating c-REL/ΔNp63α-specific interactions in these effects. We discovered that TNF-α or genetic alteration of c-REL expression inversely modulates ΔNp63α/TAp73 interactions on distinct p63 DNA-binding sites, including those for key growth arrest and apoptotic genes p21WAF1, NOXA, and PUMA. Functionally, c-REL repressed these genes and the antiproliferative effects of TNF-α or TAp73. Conversely, c-REL siRNA depletion enhanced TAp73 promoter interaction and expression of genes mediating growth arrest and apoptosis. Similar to TNF-α-treated HNSCC lines, human HNSCC tumors and hyperplastic squamous epithelia of transgenic mice overexpressing ΔNp63α that exhibit inflammation also show increased nuclear c-REL/ΔNp63α and cytoplasmic TAp73 localization. These findings unveil a novel and reversible dynamic mechanism whereby proinflammatory cytokine TNF-α-induced c-REL/ΔNp63α interactions inactivate tumor suppressor TAp73 function, promoting TNF-α resistance and cell survival in cancers with mtTP53. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933882      PMCID: PMC3206154          DOI: 10.1158/0008-5472.CAN-11-2460

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  Expression of TNF and the 55-kDa TNF receptor in epidermis, oral mucosa, lichen planus and squamous cell carcinoma.

Authors:  F Younes; E L Quartey; S Kiguwa; M Partridge
Journal:  Oral Dis       Date:  1996-03       Impact factor: 3.511

2.  ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.

Authors:  Xinping Yang; Hai Lu; Bin Yan; Rose-Anne Romano; Yansong Bian; Jay Friedman; Praveen Duggal; Clint Allen; Ryan Chuang; Reza Ehsanian; Han Si; Satrajit Sinha; Carter Van Waes; Zhong Chen
Journal:  Cancer Res       Date:  2011-05-15       Impact factor: 12.701

3.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

4.  TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB.

Authors:  C Y Wang; M W Mayo; A S Baldwin
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

5.  A mutant Rel-homology domain promotes transcription by p50/NFkappaB1.

Authors:  X Xu; C Gélinas
Journal:  Oncogene       Date:  1997-04-03       Impact factor: 9.867

6.  The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.

Authors:  Matthew D Westfall; Deborah J Mays; Joseph C Sniezek; Jennifer A Pietenpol
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation.

Authors:  C Kunsch; S M Ruben; C A Rosen
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

8.  Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor.

Authors:  A A Beg; A S Baldwin
Journal:  Oncogene       Date:  1994-05       Impact factor: 9.867

Review 9.  The c-Rel transcription factor and B-cell proliferation: a deal with the devil.

Authors:  Thomas D Gilmore; Demetrios Kalaitzidis; Mei-Chih Liang; Daniel T Starczynowski
Journal:  Oncogene       Date:  2004-03-25       Impact factor: 9.867

10.  Inhibition of transcription factor nuclear factor-kappaB by a mutant inhibitor-kappaBalpha attenuates resistance of human head and neck squamous cell carcinoma to TNF-alpha caspase-mediated cell death.

Authors:  D C Duffey; C V Crowl-Bancroft; Z Chen; F G Ondrey; M Nejad-Sattari; G Dong; C Van Waes
Journal:  Br J Cancer       Date:  2000-11       Impact factor: 7.640

View more
  44 in total

1.  ΔNp63α represses anti-proliferative genes via H2A.Z deposition.

Authors:  Corrie L Gallant-Behm; Matthew R Ramsey; Claire L Bensard; Ignacio Nojek; Jack Tran; Minghua Liu; Leif W Ellisen; Joaquín M Espinosa
Journal:  Genes Dev       Date:  2012-09-26       Impact factor: 11.361

2.  PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis.

Authors:  Luojing Chen; Matthew S Hayden; Elaine S Gilmore; Carolina Alexander-Savino; David Oleksyn; Kathleen Gillespie; Jiyong Zhao; Brian Poligone
Journal:  Carcinogenesis       Date:  2018-03-08       Impact factor: 4.944

3.  HSP90 Inhibitor SNX5422/2112 Targets the Dysregulated Signal and Transcription Factor Network and Malignant Phenotype of Head and Neck Squamous Cell Carcinoma.

Authors:  Jay A Friedman; Stephanie C Wise; Michael Hu; Chris Gouveia; Robert Vander Broek; Christian Freudlsperger; Vishnu R Kannabiran; Pattatheyil Arun; James B Mitchell; Zhong Chen; Carter Van Waes
Journal:  Transl Oncol       Date:  2013-08-01       Impact factor: 4.243

4.  Mutations in RIPK4 cause the autosomal-recessive form of popliteal pterygium syndrome.

Authors:  Ersan Kalay; Orhan Sezgin; Vasant Chellappa; Mehmet Mutlu; Heba Morsy; Hulya Kayserili; Elmar Kreiger; Aysegul Cansu; Bayram Toraman; Ebtesam Mohammed Abdalla; Yakup Aslan; Shiv Pillai; Nurten A Akarsu
Journal:  Am J Hum Genet       Date:  2011-12-22       Impact factor: 11.025

Review 5.  The p53 circuit board.

Authors:  Kelly D Sullivan; Corrie L Gallant-Behm; Ryan E Henry; Jean-Luc Fraikin; Joaquín M Espinosa
Journal:  Biochim Biophys Acta       Date:  2012-02-07

6.  Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.

Authors:  Heather M Walline; Christine M Goudsmit; Jonathan B McHugh; Alice L Tang; John H Owen; Bin T Teh; Erin McKean; Thomas W Glover; Martin P Graham; Mark E Prince; Douglas B Chepeha; Steven B Chinn; Robert L Ferris; Susanne M Gollin; Thomas K Hoffmann; Henning Bier; Ruud Brakenhoff; Carol R Bradford; Thomas E Carey
Journal:  Head Neck       Date:  2017-02-25       Impact factor: 3.147

7.  Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.

Authors:  Katherine A Hoadley; Christina Yau; Denise M Wolf; Andrew D Cherniack; David Tamborero; Sam Ng; Max D M Leiserson; Beifang Niu; Michael D McLellan; Vladislav Uzunangelov; Jiashan Zhang; Cyriac Kandoth; Rehan Akbani; Hui Shen; Larsson Omberg; Andy Chu; Adam A Margolin; Laura J Van't Veer; Nuria Lopez-Bigas; Peter W Laird; Benjamin J Raphael; Li Ding; A Gordon Robertson; Lauren A Byers; Gordon B Mills; John N Weinstein; Carter Van Waes; Zhong Chen; Eric A Collisson; Christopher C Benz; Charles M Perou; Joshua M Stuart
Journal:  Cell       Date:  2014-08-07       Impact factor: 41.582

Review 8.  Caught in the cross fire: p53 in inflammation.

Authors:  Tomer Cooks; Curtis C Harris; Moshe Oren
Journal:  Carcinogenesis       Date:  2014-06-18       Impact factor: 4.944

9.  PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer.

Authors:  Amanda Herzog; Yansong Bian; Robert Vander Broek; Bradford Hall; Jamie Coupar; Hui Cheng; Anastasia L Sowers; John D Cook; James B Mitchell; Zhong Chen; Ashok B Kulkarni; Carter Van Waes
Journal:  Clin Cancer Res       Date:  2013-05-02       Impact factor: 12.531

10.  Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways.

Authors:  Xinping Yang; Hui Cheng; Jianhong Chen; Ru Wang; Anthony Saleh; Han Si; Steven Lee; Emine Guven-Maiorov; Ozlem Keskin; Attila Gursoy; Ruth Nussinov; Jugao Fang; Carter Van Waes; Zhong Chen
Journal:  Cancer Immunol Res       Date:  2019-10-17       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.